1,859
Participants
Start Date
August 31, 2005
Primary Completion Date
June 30, 2008
Study Completion Date
July 31, 2008
Omiganan 1% gel
Patients randomized to omiganan group will receive an application of omiganan gel around the catheter insertion site following catheter insertion. Every 3 days the dressing will be changed and patients will receive a new application of Omiganan 1% gel.
Povidone-Iodine 10%
All CVC sites will be disinfected using a 10% povidone-iodine scrub for a minimum of 2 minutes prior to catheter insertion. Patients randomized to the povidone-iodine group will receive no further antiseptic treatment after catheter insertion until dressing changes. Every three days the dressing will be changed and the catheter site will be sterilized with povidone-iodine.
Mobile
Phoenix
Arcadia
Glendale
Long Beach
Los Angeles
Madera
San Diego
San Francisco
Torrance
Denver
Bridgeport
Jacksonville
Miami
Fort Gordon
Marietta
Elk Grove Village
Hoffman Estates
Louisville
Opelousas
Shreveport
Saint Paul
Kansas City
Camden
Newark
Brooklyn
Jamaica
Syracuse
Oklahoma City
Pittsburgh
Memphis
El Paso
Fort Worth
Houston
Lubbock
Morgantown
Bourg-en-Bresse
Brive-la-Gaillarde
La Roche-sur-Yon
Limoges
Montauban
Orléans
Pau
Poitiers
Tours
Halle
Jena
Leipzig
Regensburg
Alcalá de Henares
Barcelona
Cadiz
El Palmar (Murcia)
Las Palmas de Gran Canaria
Madrid
Palma de Mallorca
Seville
Lead Sponsor
Cadence Pharmaceuticals
INDUSTRY